pharmaceutical regulation Archives

LegitScript’s Influence: More Harm Than Good?

Brian RogersJune 5, 20240177 views

LegitScript, a private company with significant control over major tech and payment companies, influences what medications Americans can access and purchase online. This control supports big pharmaceutical companies by blocking affordable Indian generics, maintaining high drug prices. This article argues that such overreach undermines public health and calls for greater transparency and legislative intervention to ensure Americans have access to safe and affordable medications.

Why Americans Must Turn to Cryptocurrency for Affordable Medications

Brian RogersMay 31, 20240150 views

The inability to use traditional payment methods like Visa, MasterCard, PayPal, and Venmo for purchasing affordable generic pharmaceuticals from India has inadvertently given rise to the use of cryptocurrency. This shift is not a result of criminal activity but a response to regulatory and corporate obstacles. This article explores how the blockage of normal payment channels has led to increased use of cryptocurrency, and how this shift impacts public perception and access to healthcare. By bypassing traditional payment processors influenced by Big Pharma, cryptocurrency offers a secure and legitimate method for consumers to access affordable medications, challenging the monopolistic practices that maintain high drug prices.

Prohibition Redux: The Parallel Crises of Pharmaceutical Regulation and Access in America

Brian RogersMay 29, 20240119 views

The regulatory landscape of pharmaceuticals today mirrors the unintended consequences of Prohibition in the 1920s. Entities like LegitScript exert significant influence over online platforms, favoring big pharma by limiting competition and driving up drug prices. This has led to the rise of an online black market, endangering public health. Legitimate online pharmacies, offering affordable and safe medications, are stifled by these monopolistic practices. To ensure equitable healthcare, it’s crucial to advocate for transparency and reform in pharmaceutical regulations, learning from the historical lessons of Prohibition.